Edition:
United Kingdom

Deena Beasley

UPDATE 2-U.S. regulator approves Teva migraine drug, shares rise

15 Sep 2018

Sept 14 Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved the company's new migraine treatment, a drug Teva has been banking on to help revive its fortunes.

Oklahoma Medicaid tests new tactic to curb U.S. drug costs

23 Aug 2018

LOS ANGELES A new front in the battle over the cost of expensive medicines in the United States is opening up in Oklahoma, the first state where the government's Medicaid program is negotiating contracts for prescription drugs based on how well they work.

Express Scripts staking out million dollar gene therapies

15 Aug 2018

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

RPT-FOCUS-Express Scripts staking out million dollar gene therapies

15 Aug 2018

Aug 15 Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Express Scripts staking out million-dollar gene therapies

15 Aug 2018

Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs.

Eisai/Biogen to advance Alzheimer's drug, provide fresh hope

03 Aug 2018

(In this July 24th story, corrects paragraphs 3 and 16 to clarify that Eisai executive said the trial generated positive, rather than effective, results at lower doses)

Amgen's new migraine drug hits insurance hurdles

26 Jul 2018

Amgen Inc's push to get patients on its new $575 a month migraine drug before competition emerges in September is facing barriers from insurers.

Focus: Eisai/Biogen to advance Alzheimer's drug, provide fresh hope

24 Jul 2018

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.

U.S. using DNA testing in effort to reunite families it separated

07 Jul 2018

The U.S. government, under court order to quickly reunify parents and children who were separated after crossing illegally into the United States from Mexico, has expanded its use of DNA tests to establish paternity in immigration matters.

Head of new U.S. corporate health plan cites surgery as biggest cost

21 Jun 2018

San Diego Dr. Atul Gawande, a surgeon who was named this week to head the company being formed by Amazon, Berkshire Hathaway and JPMorgan Chase to trim employee healthcare costs, on Thursday cited surgery as the single biggest U.S. healthcare cost and said there are ways to both cut costs and improve patient care.

World News